TriSalus Life Sciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €129.26M +26.8% €40.66M +63.6% 31.5% +0.071 pp N/A N/A
    (estimated) €101.96M +25.3% €24.85M +77.0% 24.4% +0.071 pp N/A N/A
    (estimated) €81.38M +38.5% €14.04M -431.2% 17.3% +0.24 pp N/A N/A
    (estimated) €58.77M +52.4% -€4.24M -83.7% -7.2% +0.60 pp N/A N/A
    (estimated) €38.57M +53.6% -€26.07M -8.0% -67.6% +0.45 pp N/A N/A
    €25.10M +59.0% -€28.35M -43.7% -112.9% +2.1 pp -€34.54M -19.0% -137.6% +1.3 pp
    €15.79M +49.3% -€50.36M +25.1% -318.9% +0.62 pp -€42.64M +58.6% -270.1% -0.16 pp
    €10.57M +47.6% -€40.25M +63.6% -380.6% -0.37 pp -€26.89M +47.1% -254.3% +0.0090 pp
    €7.17M +54.6% -€24.60M -9.4% -343.4% +2.4 pp -€18.29M +16,068.3% -255.2% -2.5 pp
    €4.63M -€27.15M -585.8% -€113.10K -2.4%

    Notifications